These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15009175)

  • 1. Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behçet's disease.
    Yang X; Ahmad T; Gogus F; Verity D; Wallace GR; Madanat W; Kanawati CA; Stanford MR; Fortune F; Jewell DP; Marshall SE
    Eur J Immunogenet; 2004 Feb; 31(1):11-4. PubMed ID: 15009175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemokine receptor 5 delta32 polymorphism and type 1 diabetes, Behcet's disease, and asthma: a meta-analysis.
    Song GG; Kim JH; Lee YH
    Immunol Invest; 2014; 43(2):123-36. PubMed ID: 24171669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CC chemokine receptor 5 polymorphism in Italian patients with Behcet's disease.
    Atzeni F; Boiardi L; Casali B; Farnetti E; Nicoli D; Sarzi-Puttini P; Pipitone N; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Filippini D; Paolazzi G; Salvarani C
    Rheumatology (Oxford); 2012 Dec; 51(12):2141-5. PubMed ID: 22966075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel.
    Cohen R; Metzger S; Nahir M; Chajek-Shaul T
    Ann Rheum Dis; 2002 Feb; 61(2):157-60. PubMed ID: 11796403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CARD15 polymorphisms in Behçet's disease.
    Ahmad T; Zhang L; Gogus F; Verity D; Wallace G; Madanat W; Fayyad F; James T; Neville M; Kanawati C; Fortune F; Celik A; Stanford M; Jewell DP; Marshall SE
    Scand J Rheumatol; 2005; 34(3):233-7. PubMed ID: 16134731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HLA-B51 subtypes and Behçet's disease in Spain.
    González-Escribano MF; Rodríguez MR; Walter K; Sanchez-Roman J; García-Lozano JR; Núñez-Roldán A
    Tissue Antigens; 1998 Jul; 52(1):78-80. PubMed ID: 9714478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behçet's disease.
    Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Shiina T; Nomura E; Onari K; Ohno S; Inoko H
    Tissue Antigens; 2001 Sep; 58(3):181-4. PubMed ID: 11703826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strong association between HLA-B*5101 and Behçet's disease in Greek patients.
    Mizuki N; Ohno S; Ando H; Chen L; Palimeris GD; Stavropoulos-Ghiokas E; Ishihara M; Goto K; Nakamura S; Shindo Y; Isobe K; Ito N; Inoko H
    Tissue Antigens; 1997 Jul; 50(1):57-60. PubMed ID: 9243757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease.
    Paul M; Klein T; Krause I; Molad Y; Narinsky R; Weinberger A
    Tissue Antigens; 2001 Sep; 58(3):185-6. PubMed ID: 11703827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absence of disease-specific polymorphisms within the HLA-B51 gene that is the susceptible locus for Behçet's disease.
    Sano K; Yabuki K; Imagawa Y; Shiina T; Mizuki N; Ohno S; Kulski JK; Inoko H
    Tissue Antigens; 2001 Aug; 58(2):77-82. PubMed ID: 11696219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of chemokine receptor 5 (CCR5) delta32 mutation with Behçet's disease is dependent on gender in Iranian patients.
    Mojtahedi Z; Ahmadi SB; Razmkhah M; Azad TK; Rajaee A; Ghaderi A
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S91-4. PubMed ID: 17067435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease.
    Duymaz-Tozkir J; Gül A; Uyar FA; Ozbek U; Saruhan-Direskeneli G
    Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S15-8. PubMed ID: 14727453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between polymorphisms of FCRL3, a non-HLA gene, and Behçet's disease in a Chinese population with ophthalmic manifestations.
    Li K; Zhao M; Hou S; Du L; Kijlstra A; Yang P
    Mol Vis; 2008; 14():2136-42. PubMed ID: 19050767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients.
    Kera J; Mizuki N; Ota M; Katsuyama Y; Pivetti-Pezzi P; Ohno S; Inoko H
    Tissue Antigens; 1999 Dec; 54(6):565-71. PubMed ID: 10674970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease.
    Park SH; Park KS; Seo YI; Min DJ; Kim WU; Kim TG; Cho CS; Mok JW; Park KS; Kim HY
    J Korean Med Sci; 2002 Jun; 17(3):366-70. PubMed ID: 12068141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GIMAP and Behçet disease: no association in the European population.
    Ortiz-Fernández L; Conde-Jaldón M; García-Lozano JR; Montes-Cano MA; Ortego-Centeno N; Castillo-Palma MJ; Espinosa G; Graña-Gil G; Sánchez-Bursón J; González-Gay MA; Barnosi-Marín AC; Solans R; Fanlo P; Rodríguez Carballeira M; Camps T; Castañeda S; Martín J; González-Escribano MF
    Ann Rheum Dis; 2014 Jul; 73(7):1433-4. PubMed ID: 24625627
    [No Abstract]   [Full Text] [Related]  

  • 17. Behçet's disease in HLA-B*51 negative Germans and Turks shows association with HLA-Bw4-80I.
    Kuranov AB; Kötter I; Henes JC; Abisheva ST; Steiert I; Riewerts F; Momynaliev KT; Müller CA
    Arthritis Res Ther; 2014 May; 16(3):R116. PubMed ID: 24887019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behçet's disease.
    Mizuki N; Yabuki K; Ota M; Katsuyama Y; Ando H; Nomura E; Funakoshi K; Davatchi F; Chams H; Nikbin B; Ghaderi AA; Ohno S; Inoko H
    Tissue Antigens; 2002 Nov; 60(5):396-9. PubMed ID: 12492815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CC chemokine receptor polymorphism CCR5Δ32 in Portuguese Behçet's disease patients.
    Bettencourt A; Leal B; Carvalho C; Oliveira R; Martins Silva A; Vaz Patto J; Bastos M; Costa L; Costa PP; Vasconcelos C; Correia J; Silva BM
    Clin Exp Rheumatol; 2014; 32(4 Suppl 84):S72-4. PubMed ID: 25268662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
    Song GG; Lee YH
    Immunol Invest; 2014; 43(4):299-311. PubMed ID: 24295368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.